Dr. Kakkar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-726-2677
Education & Training
Massachusetts General HospitalFellowship, Cardiovascular Disease, 2007 - 2011
Brigham and Women's HospitalResidency, Internal Medicine, 2005 - 2007
Tufts University School of MedicineClass of 2002
Certifications & Licensure
MA State Medical License 2007 - 2025- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 5 citationsRace, Interleukin-6,Genotype, and Cardiovascular Disease in Patients With Chronic Kidney Disease.Ian R Barrows, Matt Devalaraja, Rahul Kakkar, Jing Chen, Jayanta Gupta
Journal of the American Heart Association. 2022-09-20 - 6 citationsLeft ventricular mass regression, all-cause and cardiovascular mortality in chronic kidney disease: a meta-analysis.Kevin C Maki, Meredith L Wilcox, Mary R Dicklin, Rahul Kakkar, Michael H Davidson
BMC Nephrology. 2022-01-16 - 1 citationsA Phase 1 Randomized Dose-Escalation Study of a Human Monoclonal Antibody to IL-6 in CKD.Kristen L Nowak, Rahul Kakkar, Matt Devalaraja, Larry Lo, Wansu Park
Kidney360. 2021-02-25
Press Mentions
‘Online Classes Takes a Toll on Students’ Mental Health’April 10th, 2021
Pandion Therapeutics Appoints John S. Sundy, M.D., Ph.D., as Chief Medical OfficerMay 19th, 2020
Pandion Therapeutics Announces Close of $80 Million Series B FinancingApril 1st, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
